Search

Your search keyword '"McGee, Elisabeth"' showing total 63 results

Search Constraints

Start Over You searched for: Author "McGee, Elisabeth" Remove constraint Author: "McGee, Elisabeth"
63 results on '"McGee, Elisabeth"'

Search Results

1. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

2. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

3. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities

4. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

5. Exploring Blended Learning Relationships in Higher Education Using a Systems-Based Framework

6. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

7. De novo variants in DENND5B cause a neurodevelopmental disorder

8. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

9. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

10. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

11. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

12. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

13. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

14. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

15. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

16. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

17. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

18. De novo variants in DENND5B cause a neurodevelopmental disorder

19. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

20. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

22. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

23. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

24. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

25. Delivering Virtual Labs in Rehabilitative Sciences during COVID-19: Strategies and Instructional Cases

26. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

27. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

28. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

29. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

30. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

31. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

32. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

33. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

34. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

35. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

36. Loss-of-function in RBBP5results in a syndromic neurodevelopmental disorder associated with microcephaly

37. Dominant missense variants in SREBF2are associated with complex dermatological, neurological, and skeletal abnormalities

38. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

39. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

40. Family law.

41. Biallelic CRELD1variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

42. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

43. Simulation Scaffolding in Occupational Therapy Curriculum: Development & Implementation.

44. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

45. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

46. An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

47. Family law.

48. Miscellaneous.

49. Criminal law.

50. De novo variants in MRTFBhave gain-of-function activity in Drosophilaand are associated with a novel neurodevelopmental phenotype with dysmorphic features

Catalog

Books, media, physical & digital resources